FIRST TRUST ADVISORS LP
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1125816
Wheaton, IL
Position in HRMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,938,799
+$4,010,382 QoQ
Shares Held
190,574
+82.3% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 328 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. HRMY ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in HRMY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,938,799 | 190,574 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,928,417 | 104,549 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,813,346 | 155,354 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,120,232 | 113,216 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,861,709 | 122,206 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,325,538 | 100,197 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,829,363 | 169,409 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,903,960 | 47,599 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,094,461 | 69,422 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $406,150 | 12,095 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,138,478 | 35,247 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $342,905 | 10,464 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $2,813,581 | 86,174 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,226,790 | 203,753 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,451,373 | 190,819 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,215,062 | 168,445 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,900,760 | 162,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,887,610 | 114,625 | Shares | Sole | 2022-02-08 | |
| 2020-09-30 | $2,068,917 | 61,030 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||